FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component

48798 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Existential restriction modifier (core metadata concept)
Members targetComponentId
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades duodenal wall (ampulla of Vater) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades duodenal wall (ampulla of Vater) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis (renal pelvis and ureter) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis (renal pelvis and ureter) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (appendix) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (appendix) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (colon/rectum) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (colon/rectum) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (esophagus) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (esophagus) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (small intestine) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (small intestine) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria or subserosa (stomach) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria or subserosa (stomach) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 8 cm in greatest dimension (bone) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 8 cm in greatest dimension (bone) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) American Joint Committee on Cancer pT2 (qualifier value)
pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) pT2a (AJCC)
pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) pT2a (AJCC)
pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) pT2a (AJCC)
pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) pT2a (AJCC)
pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) pT2a (AJCC)
pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) pT2a (AJCC)
pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) pT2a (AJCC)
pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) pT2a (AJCC)
pT2a category pT2a (AJCC)
pT2a category pT2a (AJCC)
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) pT2a (AJCC)
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) pT2a (AJCC)
pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) pT2a (AJCC)
pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) pT2a (AJCC)
pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) pT2a (AJCC)
pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) pT2a (AJCC)
pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) pT2a (AJCC)
pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) pT2a (AJCC)
pT2a: Tumor invades muscularis propria (stomach) pT2a (AJCC)
pT2a: Tumor invades muscularis propria (stomach) pT2a (AJCC)
pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) pT2a (AJCC)
pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) pT2a (AJCC)
pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) pT2a (AJCC)
pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) pT2a (AJCC)
pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) pT2a (AJCC)
pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) pT2a (AJCC)
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) pT2a (AJCC)
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) pT2a (AJCC)
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) pT2a (AJCC)
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) pT2a (AJCC)
pT2a: Unilateral, one-half of one lobe or less (prostate) pT2a (AJCC)
pT2a: Unilateral, one-half of one lobe or less (prostate) pT2a (AJCC)
pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT2b (qualifier value)
pT2b category American Joint Committee on Cancer pT2b (qualifier value)

Start Previous Page 484 of 488 Next End

Reference Sets

Reference set descriptor

Back to Start